Craft
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
banner
G1 Therapeutics financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.

Stock Price

$3.3

2024-03-19

Market Capitalization

$171.2 M

2024-03-19

Revenue

$82.5 M

FY, 2023

CreditSafe Score

?
Score changed on Apr 16, 2024
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn more

Financial Statements

USDFY, 2020FY, 2021FY, 2022FY, 2023
Revenue45.3M31.5M51.3M82.5M
Cost of goods sold2.0M3.7M
Gross profit29.5M47.6M
Gross profit margin, %93.6%92.7%
General and administrative expense68.5M95.7M100.4M71.1M
Operating expense total141.8M171.9M183.7M114.8M
EBIT(96.5M)(142.5M)(136.2M)(39.5M)
EBIT margin, %-213.0%-452.6%-265.4%-47.9%
Interest income952.0K43.0K748.0K
Interest expense1.8M4.7M10.4M8.8M
Pre tax profit(97.8M)(147.4M)(145.9M)(44.9M)
Income tax expense1.4M925.0K1.7M3.1M
Net Income(99.3M)(148.4M)(147.6M)(48.0M)
EPS(2.6)(3.5)(3.4)(0.9)

Footer menu